Dataset from A Phase 1, Randomized, Single Blind, Placebo Controlled, Single Ascending Dose and Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneously Administered ALN PCSSC in Subjects With Elevated Low Density Lipoprotein Cholesterol
收藏NIAID Data Ecosystem2026-05-10 收录
下载链接:
https://doi.org/10.25934/PR00012351
下载链接
链接失效反馈官方服务:
资源简介:
The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of ALN-PCSSC in subjects with elevated LDL-C.
创建时间:
2025-12-16



